318 related articles for article (PubMed ID: 35328682)
1. Artificial Intelligence Technologies for COVID-19 De Novo Drug Design.
Floresta G; Zagni C; Gentile D; Patamia V; Rescifina A
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328682
[TBL] [Abstract][Full Text] [Related]
2.
Bung N; Krishnan SR; Bulusu G; Roy A
Future Med Chem; 2021 Mar; 13(6):575-585. PubMed ID: 33590764
[No Abstract] [Full Text] [Related]
3. A call to arms.
Service RF
Science; 2021 Mar; 371(6534):1092-1095. PubMed ID: 33707248
[No Abstract] [Full Text] [Related]
4. Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates.
Serafim MSM; Gertrudes JC; Costa DMA; Oliveira PR; Maltarollo VG; Honorio KM
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33624754
[TBL] [Abstract][Full Text] [Related]
5. Fighting COVID-19 with Artificial Intelligence.
Monteleone S; Kellici TF; Southey M; Bodkin MJ; Heifetz A
Methods Mol Biol; 2022; 2390():103-112. PubMed ID: 34731465
[TBL] [Abstract][Full Text] [Related]
6. An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19.
Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
Biomed Res Int; 2021; 2021():8853056. PubMed ID: 34258282
[TBL] [Abstract][Full Text] [Related]
7. Molecular Insights into Small-Molecule Drug Discovery for SARS-CoV-2.
Su H; Zhou F; Huang Z; Ma X; Natarajan K; Zhang M; Huang Y; Su H
Angew Chem Int Ed Engl; 2021 Apr; 60(18):9789-9802. PubMed ID: 32729180
[TBL] [Abstract][Full Text] [Related]
8.
Domenico A; Nicola G; Daniela T; Fulvio C; Nicola A; Orazio N
J Chem Inf Model; 2020 Oct; 60(10):4582-4593. PubMed ID: 32845150
[TBL] [Abstract][Full Text] [Related]
9. Drugmonizome and Drugmonizome-ML: integration and abstraction of small molecule attributes for drug enrichment analysis and machine learning.
Kropiwnicki E; Evangelista JE; Stein DJ; Clarke DJB; Lachmann A; Kuleshov MV; Jeon M; Jagodnik KM; Ma'ayan A
Database (Oxford); 2021 Mar; 2021():. PubMed ID: 33787872
[TBL] [Abstract][Full Text] [Related]
10. Screening of Severe Acute Respiratory Syndrome Coronavirus 2 RNA-Dependent RNA Polymerase Inhibitors Using Computational Approach.
Dhankhar P; Dalal V; Kumar V
J Comput Biol; 2021 Dec; 28(12):1228-1247. PubMed ID: 34847746
[TBL] [Abstract][Full Text] [Related]
11. Artificial Intelligence in Accelerating Drug Discovery and Development.
Tripathi A; Misra K; Dhanuka R; Singh JP
Recent Pat Biotechnol; 2023; 17(1):9-23. PubMed ID: 35927896
[TBL] [Abstract][Full Text] [Related]
12. Application of artificial intelligence and machine learning for COVID-19 drug discovery and vaccine design.
Lv H; Shi L; Berkenpas JW; Dao FY; Zulfiqar H; Ding H; Zhang Y; Yang L; Cao R
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34410360
[TBL] [Abstract][Full Text] [Related]
13. Artificial intelligence in COVID-19 drug repurposing.
Zhou Y; Wang F; Tang J; Nussinov R; Cheng F
Lancet Digit Health; 2020 Dec; 2(12):e667-e676. PubMed ID: 32984792
[TBL] [Abstract][Full Text] [Related]
14. Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening.
Federico LB; Silva GM; da Silva Hage-Melim LI; Gomes SQ; Barcelos MP; Galindo Francischini IA; Tomich de Paula da Silva CH
Future Med Chem; 2021 Aug; 13(16):1353-1366. PubMed ID: 34169729
[No Abstract] [Full Text] [Related]
15. Active Learning and the Potential of Neural Networks Accelerate Molecular Screening for the Design of a New Molecule Effective against SARS-CoV-2.
Yassine R; Makrem M; Farhat F
Biomed Res Int; 2021; 2021():6696012. PubMed ID: 34124259
[TBL] [Abstract][Full Text] [Related]
16. The role of chemical biology in the fight against SARS-CoV-2.
Burslem GM
Biochem J; 2021 Jan; 478(1):157-177. PubMed ID: 33439990
[TBL] [Abstract][Full Text] [Related]
17. Evolutionary artificial intelligence based peptide discoveries for effective Covid-19 therapeutics.
Kabra R; Singh S
Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165978. PubMed ID: 32980462
[TBL] [Abstract][Full Text] [Related]
18. Indian contribution toward biomedical research and development in COVID-19: A systematic review.
Kaur H; Kaur M; Bhattacharyya A; Prajapat M; Thota P; Sarma P; Kumar S; Kaur G; Sharma S; Prakash A; Saifuddin PK; Medhi B
Indian J Pharmacol; 2021; 53(1):63-72. PubMed ID: 33976001
[TBL] [Abstract][Full Text] [Related]
19. Antiviral drug discovery: preparing for the next pandemic.
Adamson CS; Chibale K; Goss RJM; Jaspars M; Newman DJ; Dorrington RA
Chem Soc Rev; 2021 Mar; 50(6):3647-3655. PubMed ID: 33524090
[TBL] [Abstract][Full Text] [Related]
20. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
Kashyap K; Siddiqi MI
Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
